Yeah, the plan is just HOLD.
We have the cash, we have the technology. On a fundamentals basis it it just needs to keep on giving. On a risk vs reward basis there is absolutely no reason to think it won't.
EXCEPT
For a panic driven fire sale.
Believe you me, there is big money out there absolutely beside themselves with joy at this perfect fortuitous worldwide economic maelstrom that is destroying the value of this wonderful company. Make no mistake, fear mongering that drives the SP down, totally out of proportion to the rest of the market, will not be allowed to recover as rapidly as the rest of the market.
Hopefully, the majority of the money in Neuren will thumb its nose at any predators and allow loyalists to keep the dream of acheiving a fair price for their investment alive.
That fair price should match the objective intrinsic fundamental value of the company at the time of any sale, rather than the vagaries of an irrational market.
It can happen, but it will require belief and nerve.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Share Price, page-14850
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 14.170 |
2 | 1626 | 14.160 |
1 | 1000 | 14.100 |
2 | 2963 | 14.030 |
3 | 2000 | 14.000 |
Price($) | Vol. | No. |
---|---|---|
14.230 | 3278 | 1 |
14.250 | 2027 | 3 |
14.260 | 2920 | 1 |
14.270 | 1191 | 1 |
14.300 | 1163 | 2 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online